Metagenomi Therapeutics, Inc. (MGX)

NASDAQ: MGX · Real-Time Price · USD

1.750

+0.120 (7.36%)

At close: Jan 22, 2026, 4:00 PM EST

1.760

+0.010 (0.57%)

After-hours: Jan 22, 2026, 7:51 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Ionis	21.92M	Log In	Log In
Ionis Growth	19466.96%	Log In	Log In
Moderna	18.12M	Log In	Log In
Moderna Growth	24.80%	Log In	Log In
Affini-T	4.72M	Log In	Log In
Affini-T Growth	83.74%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	44.76M	Log In	Log In
United States Growth	160.21%	Log In	Log In